UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
|
|
|
Date of Report (date of earliest event reported)
|
Establishment Labs Holdings Inc.
(Exact name of registrant as specified in
its charter)
|
| | | | | | |
British Virgin Islands | | Not applicable |
(State or other jurisdiction of
incorporation or organization) | (Commission
File No.)
| (I.R.S. Employer
Identification Number) |
Building B15 and 25 Coyol Free Zone Alajuela Costa Rica |
(Address of principal executive offices) (Zip Code) |
| +506 2434 2400 | |
| (Registrant’s telephone
number, including area code) | |
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8‑K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | |
¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
¨ | Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
| | |
Title of each class | Trading symbol | Name of each exchange on which registered |
Common Shares, No Par Value | ESTA | The
NASDAQ Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2) of this chapter. Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Stock Option Grants
On June 26, 2020, the Compensation Committee approved the grant of stock options to certain of our executive officers. The following table sets forth the number of shares underlying the stock option grants to certain named executive officers:
|
| | | | |
Named
Executive Officer | | Position | | Stock Options |
| | Chief Financial Officer | | 35,000 |
The stock options described above were granted under our 2018 Equity Incentive Plan and have a per share exercise
price equal to $17.03, the closing price of our common shares as reported on The Nasdaq Capital Market on June 26, 2020.
The grant of 35,000 options for Renee M. Gaeta is subject to a four-year vesting schedule, with 25% vesting one year after a vesting commencement date of June 26, 2020 and 25% each one year anniversary thereafter, subject to her continued service with us.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. |
| | | | |
| | | | ESTABLISHMENT LABS HOLDINGS INC. |
| | | | |
Dated: | | | By: | |
| | | Name: | |
| | | Title: | Chief
Financial Officer |
| | | | |
